Literature DB >> 23945279

Infectious neuropathies.

Christian J M Sindic1.   

Abstract

PURPOSE OF REVIEW: Infectious neuropathies are heterogeneous neuropathies with multiple causes. They still represent an important world health burden and some of them have no current available therapy. RECENT
FINDINGS: Leprosy incidence has decreased by 50% during the last years, but leprosy-related neuropathies still cause severe disability. The pure neuritic leprosy is a diagnostic challenge that may require nerve biopsy or nerve aspiration cytology. The treatment itself may lead to a 'reversal reaction', which further causes injuries to the nerve. HCV-related neuropathies may be related or not to the presence of cryoglobulins. The absence of vasculitis, the most frequent form is a peripheral sensory neuropathy involving small nerve fibers, and more accurately diagnosed by pain-related evoked potentials. HIV-related neuropathy has become the major neurological complication of HIV infection. Both HIV-induced neuropathy and antiretroviral toxic neuropathy are clinically indistinguishable. The existence of an isolated chronic polyneuropathy due to Borrelia burgdorferi remains highly controversial. Lastly, an active infectious ganglioneuritis caused by varicella zoster virus, producing shingles, is the most frequent infectious neuropathy in the world and may cause various neurological complications. Zoster sine herpete remains frequently undiagnosed.
SUMMARY: Recent data have improved our knowledge and diagnostic tools of infectious neuropathies. Treatment of the injured nerves is not yet available, and prevention and rapid diagnosis remain the main priorities for the clinician.

Entities:  

Mesh:

Year:  2013        PMID: 23945279     DOI: 10.1097/WCO.0b013e328364c036

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  7 in total

1.  Peripheral neuropathy in leprosy: Clinical manifestations and disability in a Colombian national referral center.

Authors:  Laura Trujillo-Ramirez; María Alejandra Palacios-Ariza; Ivan Pradilla; Luis Arturo Gamboa
Journal:  Dermatol Reports       Date:  2021-08-05

2.  M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator.

Authors:  Nawal Bahia El Idrissi; Pranab K Das; Kees Fluiter; Patricia S Rosa; Jeroen Vreijling; Dirk Troost; B Paul Morgan; Frank Baas; Valeria Ramaglia
Journal:  Acta Neuropathol       Date:  2015-03-15       Impact factor: 17.088

Review 3.  Neuropathic cancer pain: What we are dealing with? How to manage it?

Authors:  Ece Esin; Suayib Yalcin
Journal:  Onco Targets Ther       Date:  2014-04-17       Impact factor: 4.147

4.  Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase.

Authors:  Lei Huang; Rong Ou; Guilherme Rabelo de Souza; Thiago M Cunha; Henrique Lemos; Eslam Mohamed; Lingqian Li; Gabriela Pacholczyk; Janice Randall; David H Munn; Andrew L Mellor
Journal:  PLoS Pathog       Date:  2016-05-11       Impact factor: 6.823

5.  Imaging Review of Peripheral Nerve Injuries in Patients with COVID-19.

Authors:  Claire E Fernandez; Colin K Franz; Jason H Ko; James M Walter; Igor J Koralnik; Shivani Ahlawat; Swati Deshmukh
Journal:  Radiology       Date:  2020-12-01       Impact factor: 11.105

6.  Immune-mediated vincristine-induced neuropathy: Unlocking therapies.

Authors:  Masha G Savelieff; Eva L Feldman
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

Review 7.  The Interplay Between Neuroinfections, the Immune System and Neurological Disorders: A Focus on Africa.

Authors:  Leonard Ngarka; Joseph Nelson Siewe Fodjo; Esraa Aly; Willias Masocha; Alfred K Njamnshi
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.